KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Debt Ratio (2016 - 2025)

Alnylam Pharmaceuticals' Debt Ratio history spans 8 years, with the latest figure at 0.03 for Q3 2025.

  • For Q3 2025, Debt Ratio changed N/A year-over-year to 0.03; the TTM value through Sep 2025 reached 0.03, changed N/A, while the annual FY2024 figure was 0.02, N/A changed from the prior year.
  • Debt Ratio reached 0.03 in Q3 2025 per ALNY's latest filing, down from 0.03 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.19 in Q4 2021 to a low of 0.02 in Q4 2024.
  • Average Debt Ratio over 3 years is 0.06, with a median of 0.03 recorded in 2025.
  • The largest YoY upside for Debt Ratio was 230.35% in 2021 against a maximum downside of 230.35% in 2021.
  • A 3-year view of Debt Ratio shows it stood at 0.19 in 2021, then tumbled by 88.07% to 0.02 in 2024, then rose by 13.04% to 0.03 in 2025.
  • Per Business Quant, the three most recent readings for ALNY's Debt Ratio are 0.03 (Q3 2025), 0.03 (Q2 2025), and 0.03 (Q1 2025).